We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$1.48B
AUM Growth
+$32M
Cap. Flow
+$45.1M
Cap. Flow %
3.05%
Top 10 Hldgs %
12.82%
Holding
987
New
371
Increased
2
Reduced
19
Closed
197
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBAI
151
MBody AI Ltd. Ordinary Share
MBAI
$8.93M
$3.35M 0.23%
+18,670
New +$4.09M
LITTU
152
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
$3.23M 0.22%
+325,000
New +$3.25M
PWP icon
153
Perella Weinberg Partners
PWP
$1.04B
$3.21M 0.22%
+250,000
New +$2.95M
SPAQ
154
DELISTED
Spartan Acquisition Corp. III
SPAQ
$3.18M 0.21%
+325,000
New +$3.2M
LJAQ
155
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
$3.17M 0.21%
325,000
ZVRA icon
156
Zevra Therapeutics
ZVRA
$692M
$3.13M 0.21%
+244,274
New +$2.63M
ZGYH
157
DELISTED
Yunhong International Class A Ordinary Shares
ZGYH
$3.11M 0.21%
306,227
-43,773
-13% -$442K
RONI.U
158
DELISTED
Rice Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RONI.U
$3.07M 0.21%
+300,000
New +$3.05M
CFFVU
159
DELISTED
CF Acquisition Corp. V Unit
CFFVU
$3.06M 0.21%
300,000
ENVXW
160
DELISTED
Enovix Corporation Warrant
ENVXW
$3.05M 0.21%
295,933
BREZ
161
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$3.01M 0.2%
300,000
REVB icon
162
Revelation Biosciences
REVB
$3.63M
$3M 0.2%
1
FPAC
163
DELISTED
Far Peak Acquisition Corporation
FPAC
$2.98M 0.2%
300,000
YAC
164
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$2.96M 0.2%
300,000
EQD
165
DELISTED
Equity Distribution Acquisition Corp.
EQD
$2.96M 0.2%
300,000
SRSA
166
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$2.96M 0.2%
300,000
MAQC
167
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$2.95M 0.2%
+300,000
New +$2.98M
FMIV
168
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
$2.93M 0.2%
+300,000
New +$2.93M
SCOA
169
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
$2.93M 0.2%
300,000
PIAI
170
DELISTED
Prime Impact Acquisition I
PIAI
$2.92M 0.2%
300,000
RUM icon
171
RUM Group Inc
RUM
$4.07B
$2.92M 0.2%
+300,000
New +$2.93M
PGRW
172
DELISTED
Progress Acquisition Corp. Class A Common Stock
PGRW
$2.92M 0.2%
300,000
RGTI icon
173
Rigetti Computing
RGTI
$5.04B
$2.91M 0.2%
+300,000
New +$2.94M
BLUA
174
DELISTED
BlueRiver Acquisition Corp.
BLUA
$2.91M 0.2%
300,000
DNZ
175
DELISTED
D and Z Media Acquisition Corp.
DNZ
$2.91M 0.2%
300,000

Similar funds

CVI Holdings's Q2 2021 Portfolio in Review

As of Q2 2021, CVI Holdings held 987 positions worth $1.48B, up 2.2% from $1.45B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

CVI Holdings deployed $45.1M of net new capital in Q2 2021, opening 371 new positions and adding to 2 existing holdings. Its largest new stake was FTAC Hera Acquisition Corp. Class A Ordinary Shares: 2,000,000 shares worth $19.5M.

By sector, the portfolio is most concentrated in Financials at 51% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Nuvation Bio, an estimated $11M trimmed.

  • CVI Holdings's largest Q2 2021 buy was FTAC Hera Acquisition Corp. Class A Ordinary Shares: 2,000,000 shares worth $19.5M.
  • CVI Holdings added most to Blue Owl Capital in Q2 2021, an estimated $19.1M increase.
  • CVI Holdings's biggest Q2 2021 reduction was Nuvation Bio, cutting an estimated $11M.
  • CVI Holdings fully exited Piedmont Lithium Limited American Depositary Receipts in Q2 2021, selling an estimated $38.6M.
  • CVI Holdings's ten largest holdings make up 13% of its $1.48B portfolio in Q2 2021.
  • CVI Holdings opened 371 new positions and closed 197 in Q2 2021.
  • CVI Holdings's portfolio value rose 2.2% quarter-over-quarter to $1.48B.

Based on CVI Holdings's 13F filing for Q2 2021, filed 11 Aug 2021.